Design the therapy: Insights from our 2026 Drug Delivery Innovation Summit
Explore insights from our 2026 Drug Delivery Innovation Summit on drug delivery devices, connected care, patient experience and therapy design.
エージェンティックAIを、実証段階から研究開発の加速へ
科学分野の研究開発向けエージェンティックプラットフォーム「Microsoft Discovery」に関するマイクロソフト社との協業を通じて見えてきたのは、その真の成果が「自動化」ではなく「加速」にあるということです。
Rethinking diagnostics in the fight against antimicrobial resistance
Alejandra Sanchez and Ben Wicks explore why primary care needs timely, pragmatic insight, not lab-grade certainty, to enable better antibiotic decisions and stewardship.
What does ‘fast enough’ mean in primary care antibiotic prescribing?
Time-to-result is critical for any diagnostic in primary care. Antibiotic prescribing can only be improved if results come fast enough to guide decision making. But what does ‘fast enough’ look like?
Unlocking the potential of IP-free gene editing to gain commercial advantage
CC’s transdisciplinary development team has created a way to democratise gene editing. This IP-free gene editing method avoids the timescales and costs involved with commercially licensing current CRISPR/Cas9 editing techniques.
Engineering biology is driving the new bio-industrial revolution
Engineering biology, the fusion of biology and engineering principles, will be key to solving some of humanity’s most urgent challenges – from climate change and food security to healthcare and more